147 related articles for article (PubMed ID: 8667505)
1. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome.
Slocum MM; Adams JG; Teel R; Spadone DP; Silver D
J Vasc Surg; 1996 May; 23(5):839-43. PubMed ID: 8667505
[TBL] [Abstract][Full Text] [Related]
2. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Kikta MJ; Keller MP; Humphrey PW; Silver D
Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
[TBL] [Abstract][Full Text] [Related]
3. Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia.
Walenga JM; Prechel M; Hoppensteadt D; Escalante V; Chaudhry T; Jeske WP; Bakhos M
Clin Appl Thromb Hemost; 2013 Sep; 19(5):482-7. PubMed ID: 23780399
[TBL] [Abstract][Full Text] [Related]
4. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
[TBL] [Abstract][Full Text] [Related]
5. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
[TBL] [Abstract][Full Text] [Related]
7. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.
Almeida JI; Coats R; Liem TK; Silver D
J Vasc Surg; 1998 Feb; 27(2):309-14; discussion 315-6. PubMed ID: 9510285
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Walenga JM; Prechel M; Jeske WP; Hoppensteadt D; Maddineni J; Iqbal O; Messmore HL; Bakhos M
Br J Haematol; 2008 Oct; 143(1):92-9. PubMed ID: 18671707
[TBL] [Abstract][Full Text] [Related]
10. Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay.
Leroux D; Canépa S; Viskov C; Mourier P; Herman F; Rollin J; Gruel Y; Pouplard C
J Thromb Haemost; 2012 Mar; 10(3):430-6. PubMed ID: 22235911
[TBL] [Abstract][Full Text] [Related]
11. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
[TBL] [Abstract][Full Text] [Related]
12. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
[TBL] [Abstract][Full Text] [Related]
13. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
Tonn ME; Schaiff RA; Kollef MH
Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia: current status and diagnostic challenges.
Otis SA; Zehnder JL
Am J Hematol; 2010 Sep; 85(9):700-6. PubMed ID: 20665476
[TBL] [Abstract][Full Text] [Related]
15. The incidence of heparin-induced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin.
Kim GH; Hahn DK; Kellner CP; Komotar RJ; Starke R; Garrett MC; Yao J; Cleveland J; Mayer SA; Connolly ES
J Neurosurg; 2009 Jan; 110(1):50-7. PubMed ID: 18976056
[TBL] [Abstract][Full Text] [Related]
16. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Mousa SA; Ahmad S
Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
19. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.
Asada R; Wanaka K; Walenga J; Prechel M; Miyashita K; Escalante V; Kaneko C; Hoshino N; Oosawa M; Matsuo M
Clin Appl Thromb Hemost; 2013; 19(1):37-41. PubMed ID: 22826445
[TBL] [Abstract][Full Text] [Related]
20. Perioperative thrombocytopenia in cardiac surgical patients - incidence of heparin-induced thrombocytopenia, morbidities and mortality.
Thielmann M; Bunschkowski M; Tossios P; Selleng S; Marggraf G; Greinacher A; Jakob H; Massoudy P
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1391-5. PubMed ID: 20138779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
